Contract Win to develop Portable Breath Device
Billy Boyle

News

Contract Win to develop Portable Breath Device

21 Jun, 2023

Published over 3 years ago. See the latest and most current information on News.

The US Defense Innovation Unit (DIU), a division of the US Department of Defense (DoD), has awarded Owlstone Medical a contract for ‘Exhaled Breath Diagnostics’, focused on the early detection of human infection using volatile organic compounds (VOCs) on breath. Under the EXHALE project the company will develop a handheld device capable of non-invasive detection of pre-symptomatic respiratory infectious disease.

For warfighters operating in remote environments where access to medical personnel is limited, the risk of detecting and contracting a respiratory disease is high and can have a severe impact on mission readiness. Most current diagnostic testing platforms are unsuitable to be deployed in the field and so there is a significant need for a portable solution.

The portable device by Owlstone will be adapted to work off battery power to detect VOCs present in exhaled breath, reducing the risk of disease transmission wherever deployed, providing a strategic advantage to the force.

Based on the Company’s proprietary FAIMS technology, the device will be developed over a two-year period, supported by clinical studies to be performed at Duke University. Initial work will focus on identifying and validating breath biomarkers for viral and bacterial pathogens and defining performance requirements for the device.

If successful, there is potential for a second phase to the project for further development of the device to the point of being ready for high-volume manufacturing by Owlstone and global deployment in the field.

Billy Boyle, co-founder and CEO at Owlstone Medical, said: “We have completed multiple studies in lung inflammation and bacterial and viral infectious disease (including COVID) with major pharma and academic partners, providing us with a broad list of candidate biomarkers for consideration in this project. We have a proprietary technology in FAIMS and extensive experience with device development and sensor design, including in small handheld devices. With proven expertise and technology in both areas, we believe Owlstone is uniquely positioned to support the EXHALE project and are pleased that the DIU agrees and has awarded us this contract.”

More information online

Latest News

ILM Guide 2026/27

Explore our Digital Edition

Discover the latest news and research

Digital edition

Explore Our Other Sites

Envirotech Online
EU ETS benchmark update puts industrial emissions data under sharper scrutiny
Explore more Arrow
Pollution Solutions Online
DNV introduces new framework for measuring onboard carbon capture performance
Explore more Arrow
Petro Online
New test method ASTM D8606 has been officially released
Explore more Arrow
Chromatography Today
Non-invasive flowmeters for real-time monitoring
Explore more Arrow